Tao Jiang
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 42
- Lung Cancer Research Studies 41
- Colorectal Cancer Treatments and Studies 14
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 75
- Lung Cancer Diagnosis and Treatment 17
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 16
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
- Molecular Biology top 5%
- Journals
- Nature (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Tao Jiang
166 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 3.2k
- Pulmonary and Respiratory Medicine 2.7k
- Cancer Research 1.0k
- Immunology 871
- Molecular Biology 1.7k
Countries citing papers authored by Tao Jiang
This map shows the geographic impact of Tao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Jiang more than expected).
Fields of papers citing papers by Tao Jiang
This network shows the impact of papers produced by Tao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Jiang. The network helps show where Tao Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 8 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 0 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 40 | |
| 11 | 2023 | 1 | |
| 12 | High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer | 2019 | 1 |
| 13 | 2019 | 121 | |
| 14 | 2019 | 23 | |
| 15 | Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patientsbreakdown → | 2018 | 390 |
| 16 | 2018 | 12 | |
| 17 | 2018 | 34 | |
| 18 | 2015 | 69 | |
| 19 | 2012 | 5 | |
| 20 | 2008 | 2 |
About Tao Jiang
Tao Jiang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 176 papers that have together received 5.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (75 papers), Cancer Immunotherapy and Biomarkers (42 papers), Lung Cancer Research Studies (41 papers), Lung Cancer Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Oncology (3.2k citations), Pulmonary and Respiratory Medicine (2.7k citations) and Cancer Research (1.0k citations). Tao Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shengxiang Ren, Caicun Zhou, Xuefei Li, Chunxia Su, Fei Zhou, Chao Zhao, Caicun Zhou, Caicun Zhou, Caicun Zhou and Xiaoxia Chen. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.